During the past decade, Gemeinschaftskrankenhaus conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gemeinschaftskrankenhaus" #1 sponsor was "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials, followed by "University Hospital Schleswig-Holstein" with 2 trials sponsored, "Universitätsklinikum Hamburg-Eppendorf" with 2 trials sponsored, "European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma" with 1 trials sponsored and "University Hospital Tuebingen" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gemeinschaftskrankenhaus" #1 collaborator was "Deutsche Kinderkrebsstiftung" with 3 trials as a collaborator, "Cooperative Weichteilsarkom Study Group" with 1 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria" with 1 trials as a collaborator and "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Gemeinschaftskrankenhaus" are "Neuroblastoma" (3 trials), "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Anaplastic Astrocytoma WHO Grade III" (1 trials), "Brain Tumors" (1 trials) and "Brain and Central Nervous System Tumors" (1 trials). Many other conditions were trialed in "Gemeinschaftskrankenhaus" in a lesser frequency.

Most popular intervention types in "Gemeinschaftskrankenhaus" are "Drug" (8 trials), "Radiation" (7 trials), "Procedure" (5 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "ifosfamide" (5 trials), "radiation therapy" (5 trials), "vindesine" (5 trials), "carboplatin" (4 trials) and "cyclophosphamide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Gemeinschaftskrankenhaus" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Gemeinschaftskrankenhaus". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Gemeinschaftskrankenhaus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gemeinschaftskrankenhaus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".